Crossmark

Blood biomarkers as surrogate endpoints of treatment responses to aerobic exercise and cognitive training (ACT) in amnestic mild cognitive impairment: the blood biomarkers study protocol of a randomized controlled trial (the ACT Trial)

Crossref DOI link: https://doi.org/10.1186/s13063-019-3798-1

Published Online: 2020-01-06

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Danni

Mielke, Michelle M.

Bell, W. Robert

Reilly, Cavan

Zhang, Lin

Lin, Feng Vankee

Yu, Fang
Funding

Funding for this research was provided by:

National Institute on Aging (R01AG059654-01)
License Information

Text and Data Mining valid from 2020-01-06

Version of Record valid from 2020-01-06
More Information

Article History

Received: 17 July 2019

Accepted: 11 October 2019

First Online: 6 January 2020

Ethics approval and consent to participate

: This study was sponsored by the NIA (NIA program official John K. Hsiao, MD, ) and approved by the UMN and UR IRBs (UMN IRB# STUDY00001835, last day of study approval 10/25/2019; UR IRB# RSRB00071626, last day of study approval 07/31/2019). The consent process was detailed in the manuscript. Informed consents are obtained from all study participants.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below